Retraction: Silencing of APE1 Enhances Sensitivity of Human Hepatocellular Carcinoma Cells to Radiotherapy In Vitro and in a Xenograft Model.

Retraction: Silencing of APE1 Enhances Sensitivity of Human Hepatocellular Carcinoma Cells to Radiotherapy In Vitro and in a Xenograft Model.

Bibliographic Details
Main Author:	PLOS ONE
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0292822

Similar Items

Retraction: Silencing of APE1 Enhances Sensitivity of Human Hepatocellular Carcinoma Cells to Radiotherapy In Vitro and in a Xenograft Model
Published: (2023-01-01)

Silencing of APE1 enhances sensitivity of human hepatocellular carcinoma cells to radiotherapy in vitro and in a xenograft model.
by: Yanping Cun, et al.
Published: (2013-01-01)

Retraction: Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies.
by: PLOS ONE Editors
Published: (2019-01-01)

Osthole Sensitizes with Radiotherapy to Suppress Tumorigenesis of Human Nasopharyngeal Carcinoma in vitro and in vivo [Retraction]
by: Peng L, et al.
Published: (2023-03-01)

Retraction: Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Clinicopathologic and prognostic significance of tumor-associated macrophages in patients with hepatocellular carcinoma: A meta-analysis.
by: PLOS ONE Editors
Published: (2023-01-01)

Retraction: Hyperthermia-Induced NDRG2 Upregulation Inhibits the Invasion of Human Hepatocellular Carcinoma via Suppressing ERK1/2 Signaling Pathway.
by: PLOS ONE Editors
Published: (2020-01-01)

Retraction: The prognostic value of prognostic nutritional index in hepatocellular carcinoma patients: A meta-analysis of observational studies.
by: PLOS ONE Editors
Published: (2022-01-01)

Retraction: MicroRNA-377 Suppresses Cell Proliferation and Invasion by Inhibiting TIAM1 Expression in Hepatocellular Carcinoma.
by: PLOS ONE Editors
Published: (2022-01-01)

Retraction: HNF-4α inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway.
by: PLOS ONE Editors
Published: (2023-01-01)

Retraction: MicroRNA-424 Is Down-Regulated in Hepatocellular Carcinoma and Suppresses Cell Migration and Invasion through c-Myb.
by: PLOS ONE Editors
Published: (2022-01-01)

Retraction: Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma.
by: PLOS ONE Editors
Published: (2023-01-01)

Retraction: RNAi-mediated silencing of vitellogenin gene curtails oogenesis in the almond moth Cadra cautella.
by: PLOS ONE Editors
Published: (2022-01-01)

Retraction: Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Alpha-Fetoprotein Promoter-Driven Cre/LoxP-Switched RNA Interference for Hepatocellular Carcinoma Tissue-Specific Target Therapy.
by: PLOS ONE Editors
Published: (2023-01-01)

Retraction: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation.
by: PLOS ONE Editors
Published: (2019-01-01)

Silencing the Girdin gene enhances radio-sensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism
by: Li Yu, et al.
Published: (2017-08-01)

Retraction: Overexpression of SATB1 Is Associated with Biologic Behavior in Human Renal Cell Carcinoma.
by: PLOS ONE Editors
Published: (2024-01-01)

Retraction: Indole-3-Carbinol Inhibits Nasopharyngeal Carcinoma Growth through Cell Cycle Arrest In Vivo and In Vitro.
by: PLOS ONE Editors
Published: (2022-01-01)

Retraction: SHBG Is an Important Factor in Stemness Induction of Cells by DHT In Vitro and Associated with Poor Clinical Features of Prostate Carcinomas.
by: PLOS ONE Editors
Published: (2020-01-01)

Silencing the expression of copine-III enhances the sensitivity of hepatocellular carcinoma cells to the molecular targeted agent sorafenib
by: Chen Z, et al.
Published: (2018-08-01)

Retraction: Recombinant Human Adenovirus-p53 Injection Induced Apoptosis in Hepatocellular Carcinoma Cell Lines Mediated by p53-Fbxw7 Pathway, Which Controls c-Myc and Cyclin E.
by: PLOS ONE Editors
Published: (2020-01-01)

Retraction: Bee venom-loaded EGFR-targeting peptide-coupled chitosan nanoparticles for effective therapy of hepatocellular carcinoma by inhibiting EGFR-mediated MEK/ERK pathway.
by: PLOS ONE Editors
Published: (2023-01-01)

Retraction: Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor γ Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome.
by: PLOS ONE Editors
Published: (2019-01-01)

Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3
by: Sameer A. Greenall, et al.
Published: (2018-08-01)

Retraction: Enhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma Progression.
by: PLOS ONE Editors
Published: (2024-01-01)

Expression of Concern: Unique Association between Global DNA Hypomethylation and Chromosomal Alterations in Human Hepatocellular Carcinoma.
by: PLOS ONE Editors
Published: (2023-01-01)

Osthole sensitizes with radiotherapy to suppress tumorigenesis of human nasopharyngeal carcinoma in vitro and in vivo
by: Peng L, et al.
Published: (2018-11-01)

Expression of Concern: Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor.
by: PLOS ONE Editors
Published: (2019-01-01)

Upregulation of miR-194-5p or silencing of PRC1 enhances radiotherapy sensitivity in esophageal squamous carcinoma cells
by: Yan Wang, et al.
Published: (2023-12-01)

Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography
by: Wu Wei-Zhong, et al.
Published: (2011-01-01)

Retraction: Differential SELEX in Human Glioma Cell Lines.
by: PLOS ONE Editors
Published: (2020-01-01)

Retraction: Overexpression of the Insulin Receptor Isoform A Promotes Endometrial Carcinoma Cell Growth.
by: PLOS ONE Editors
Published: (2021-01-01)

Remodeling Serine Synthesis and Metabolism via Nanoparticles (NPs)‐Mediated CFL1 Silencing to Enhance the Sensitivity of Hepatocellular Carcinoma to Sorafenib
by: Senlin Li, et al.
Published: (2023-07-01)

Aurora Kinase Inhibitor PHA-739358 Suppresses Growth of Hepatocellular Carcinoma In Vitro and in a Xenograft Mouse Model
by: Daniel Benten, et al.
Published: (2009-09-01)

Lentivirus mediated silencing of Ubiquitin Specific Peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro
by: Zeya Pan, et al.
Published: (2015-01-01)

Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules
by: Federica Tonon, et al.
Published: (2021-08-01)